Previous close | 3.4000 |
Open | 3.3700 |
Bid | 3.4100 x 0 |
Ask | 3.4300 x 0 |
Day's range | 3.3400 - 3.4850 |
52-week range | 2.1450 - 4.0100 |
Volume | |
Avg. volume | 226,727 |
Market cap | 1.3B |
Beta (5Y monthly) | 1.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Lord Jones® Chocolate Fusions Lord Jones® Chocolate Fusions Lord Jones® Cookies & Cream Chocolate Fusions Lord Jones® Cookies & Cream Chocolate Fusions Lord Jones® Dazzleberry Pop Chocolate Fusions Lord Jones® Dazzleberry Pop Chocolate Fusions Lord Jones® Salted Caramel Crunch Chocolate Fusions Lord Jones® Salted Caramel Crunch Chocolate Fusions TORONTO, March 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid c
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 36th Annual Roth Conference on Monday, March 18, 2024, at 8:30AM PT. A live webcast will be available on the Investors section of the Company’s website at https://ir.thecronosgroup.com/events-presentations. About Cronos Group Inc.Cronos is an innovative g
Ended 2023 with approximately $862 million in cash and short-term investments Commenced sales to Australian partner Launched award-winning Lord Jones® brand in Canada Consolidated net revenue increased 9% in Q4 2023 compared to Q4 2022; on a constant currency basis consolidated net revenue increased 11% in Q4 2023 compared to Q4 2022 Net revenue in Canada increased 20% in Q4 2023 compared to Q4 2022; on a constant currency basis net revenue in Canada increased 21% in Q4 2023 compared to Q4 2022